Council Directive 89/381/EEC of 14 June 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products and laying down special provisions for medicinal products derived from human blood or human plasma
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement Area (EEA Agreement)
Legal documents
Council Directive 89/381/EEC of 14 June 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products and laying down special provisions for medicinal products derived from human blood or human plasma
Richtlinie 89/381/EWG des Rates vom 14. Juni 1989 zur Erweiterung des Anwendungsbereichs der Richtlinien 65/65/EWG und 75/319/EWG zur Angleichung der Rechts- und Verwaltungsvorschriften über Arzneispezialitäten und zur Festlegung besonderer Vorschriften für Arzneimittel aus menschlichem Blut oder Blutplasma
History
01.01.1994
Adopted JCD confirmed entry into force date
01.01.1994
Compliance date in the EEA
01.01.1994
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
01.01.1994
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
14.06.1989
Adoption date in the EU
01.01.1992
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.